Alaunos Therapeutics (TCRT) Other Working Capital Changes (2016 - 2025)
Historic Other Working Capital Changes for Alaunos Therapeutics (TCRT) over the last 15 years, with Q3 2025 value amounting to -$166000.0.
- Alaunos Therapeutics' Other Working Capital Changes rose 5174.42% to -$166000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$356000.0, marking a year-over-year decrease of 15973.15%. This contributed to the annual value of -$539000.0 for FY2024, which is 13852.75% down from last year.
- Latest data reveals that Alaunos Therapeutics reported Other Working Capital Changes of -$166000.0 as of Q3 2025, which was up 5174.42% from -$122000.0 recorded in Q2 2025.
- Alaunos Therapeutics' 5-year Other Working Capital Changes high stood at $927000.0 for Q4 2023, and its period low was -$3.2 million during Q1 2021.
- For the 5-year period, Alaunos Therapeutics' Other Working Capital Changes averaged around -$491789.5, with its median value being -$167000.0 (2022).
- Its Other Working Capital Changes has fluctuated over the past 5 years, first soared by 195400.0% in 2023, then crashed by 52653.06% in 2024.
- Quarter analysis of 5 years shows Alaunos Therapeutics' Other Working Capital Changes stood at -$1.5 million in 2021, then soared by 96.76% to -$50000.0 in 2022, then soared by 1954.0% to $927000.0 in 2023, then plummeted by 122.44% to -$208000.0 in 2024, then increased by 20.19% to -$166000.0 in 2025.
- Its last three reported values are -$166000.0 in Q3 2025, -$122000.0 for Q2 2025, and $140000.0 during Q1 2025.